case_images: PMC9098951_01
case_images: Timeline of different treatments and disease status.
case_images: fonc-12-873198-g001.jpg
case_images: PMC9098951_01_fonc-12-873198-g001.jpg
case_images: f1
case_images: We show the treatment timeline in Figure 1.
case_images: MRI after 21 months of platinum-based chemotherapy: a large prominent tumor in the left frontal lobe with inhomogeneous signal surrounding the tumor mass representing edema. (A) Axial T2-weighted. (B) Axial gadolinium-enhanced T1-weighted FFE. (C) Coronal gadolinium-enhanced T1-weighted FFE. (D) Sagittal gadolinium-enhanced T1-FFE.
case_images: fonc-12-873198-g002.jpg
case_images: PMC9098951_01_fonc-12-873198-g002.jpg
case_images: f2
case_images: Her CA125 level had only 15.5 U/ml, and magnetic resonance imaging (MRI) detected a brain metastasis (a prominent tumor in the left frontal lobe with low-density signal surrounding the tumor mass representing edema) (Figure 2), whereas chest-abdominal and pelvic CT revealed no abnormal findings.
case_images: Changes in serum CA125 levels since the start of niraparib treatment.
case_images: fonc-12-873198-g003.jpg
case_images: PMC9098951_01_fonc-12-873198-g003.jpg
case_images: f3
case_images: So far, it has maintained a low and stable level (3.99-6.94 U/ml) (Figure 3).